Patricia A. Wood, MD, PhD | Authors

Role of Iron in Optimizing Responses of Anemic Cancer Patients to Erythropoietin

April 01, 1999

Many patients with widespread cancer develop a hypoproliferative anemia,[1-3] which is often worsened by systemic cytotoxic chemotherapy. Some chemotherapeutic agents directly depress the capacity of bone marrow cells to proliferate,